Canilang, Cecilio R.
HRN: 03-96-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
CEFTRIAXONE 1G (VIAL)
07/03/2023
07/10/2023
IV
2g
OD
T/C Cystitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes